Chronic Kidney Disease Severity and Progression to Proliferative Diabetic Retinopathy
Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11621-11631
DOI: 10.1111/dom.71368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 17.09.2026. Verfasst von Taemin Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Aims
To determine whether chronic kidney disease (CKD) severity is associated with progression from nonproliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR) and severe retinal complications. Materials and Methods In this retrospective TriNetX cohort study, adults with Type 2 diabetes and NPDR were matched 1:1 by CKD stage (1–2, 3, 4–5 or end‐stage renal disease [ESRD]) to patients without CKD. Patients with prior PDR, diabetic macular oedema, intravitreal treatment, or vitrectomy were excluded. Cox models estimated 3‐year hazard ratios (HRs) for PDR and a composite of PDR, vitreous haemorrhage, tractional retinal detachment or vitrectomy. Sensitivity analyses used laboratory‐defined estimated glomerular filtration rate and cohorts restricted to mild NPDR or documented baseline haemoglobin A1c.
Results
Matched comparisons included 8476, 24 432, 9933 and 7359 patients with CKD Stages 1–2, 3, 4–5 and ESRD, respectively, with equal‐sized reference cohorts. PDR risk increased with CKD severity: HR 1.12 (95% confidence interval [CI] 0.96–1.29) for Stages 1–2, 1.35 (1.23–1.47) for Stage 3, 1.59 (1.40–1.80) for Stages 4–5 and 1.66 (1.45–1.89) for ESRD. Similar associations were observed for the composite and persisted in laboratory‐defined and mild‐NPDR‐restricted analyses, although residual baseline haemoglobin A1c imbalance remained in advanced CKD comparisons.
Conclusions
CKD Stage 3 or higher was associated with greater progression from NPDR to PDR and severe retinal complications. CKD severity may identify higher‐risk patients, although prospective studies are needed before CKD‐specific surveillance is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
- Department of Health and Clinical Outcome Research, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
- Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
- Brown University Health, Providence, Rhode Island, USA.
- Department of Family Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
ORCID-Profile: Chien-Hsiang Weng
Zitieren
APA
Kim, T., Vu, A., Ali, Z., Kim, E., & Weng, C. H. (2026). Chronic Kidney Disease Severity and Progression to Proliferative Diabetic Retinopathy. Diabetes, Obesity and Metabolism, 28(12), 11621-11631. https://doi.org/10.1111/dom.71368
Vancouver
Kim T, Vu A, Ali Z, Kim E, Weng CH. Chronic Kidney Disease Severity and Progression to Proliferative Diabetic Retinopathy. Diabetes, Obesity and Metabolism. 2026;28(12):11621-11631. doi:10.1111/dom.71368
BibTeX
@article{Kim2026,
author = {Kim, Taemin and Vu, Anh and Ali, Zara and Kim, Eric and Weng, Chien-Hsiang},
title = {Chronic Kidney Disease Severity and Progression to Proliferative Diabetic Retinopathy},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {12},
pages = {11621--11631},
doi = {10.1111/dom.71368}
}
EUVIMED